Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Internal Medicine (Tokyo, Japan)|August 9, 2022
Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular CarcinomaToshihiko Nishioki, Ryo Koyama, Hironao Okubo, et al.Modern Rheumatology Case Reports|October 23, 2024
Anaphylaxis and prolonged allergic reactions caused by intra-articular injection of diclofenac etalhyaluronate in knee osteoarthritis: A case reportTomohito Takeshige, Ryo Koyama, Yuta Hotchi, et al.Thoracic Cancer|November 21, 2020
Impact of the generation of EGFR-TKIs administered as prior therapy on the efficacy of osimertinib in patients with non-small cell lung cancer harboring EGFR T790M mutationYosuke Miyashita, Ryo Ko, Naoko Shimada, et al.Science Advances|July 23, 2026
Distinct thymic pDC populations promote tumor immune tolerance through complementary mechanismsYangsong Wang, Ryo Koyama-Nasu, Yukihiro Endo, et al.Cancer Chemotherapy and Pharmacology|August 12, 2015
Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agentsTakehito Shukuya, Ryo Ko, Keita Mori, et al.Journal of Thoracic Disease|July 10, 2019
Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspirationEriko Kuwasaki, Tetsutaro Nagaoka, Hiroaki Ihara, et al.BMC Cancer|March 12, 2016
Cerebral infarction in advanced non-small cell lung cancer: a case control studyMotoyasu Kato, Takehito Shukuya, Keita Mori, et al.Journal of Thoracic Disease|December 4, 2012
Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancerKeiko Muraki, Ryo Koyama, Yuichiro Honma, et al.Cancer Immunology, Immunotherapy : CII|October 31, 2020
CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapyAyaka Hara, Ryo Koyama-Nasu, Mariko Takami, et al.Plos One|November 22, 2021
IFNγ suppresses the expression of GFI1 and thereby inhibits Th2 cell proliferationMurshed H Sarkar, Ryoji Yagi, Yukihiro Endo, et al.Pageof 8